NCT05554835 Global Registry and Natural History Study for Mitochondrial Disorders
| NCT ID | NCT05554835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | LMU Klinikum |
| Condition | Mitochondrial Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2009-02-01 |
| Primary Completion | 2040-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2009-02-01 with a primary completion date of 2040-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main goal of the project is provision of a global registry for mitochondrial disorders to harmonize previous national registries, enable world-wide participation and facilitate natural history studies, definition of outcome measures and conduction of clinical trials.
Eligibility Criteria
Inclusion Criteria: * suspected or confirmed mitochondrial disease * willingness to participate Exclusion Criteria: * unwillingness to participate
Contact & Investigator
Thomas Klopstock, Prof. Dr.
PRINCIPAL INVESTIGATOR
LMU Klinikum, Munich
Frequently Asked Questions
Who can join the NCT05554835 clinical trial?
This trial is open to participants of all sexes, studying Mitochondrial Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05554835 currently recruiting?
Yes, NCT05554835 is actively recruiting participants. Contact the research team at boriana.buechner@med.uni-muenchen.de for enrollment information.
Where is the NCT05554835 trial being conducted?
This trial is being conducted at Innsbruck, Austria, Salzburg, Austria, Munich, Germany, Berlin, Germany and 11 additional locations.
Who is sponsoring the NCT05554835 clinical trial?
NCT05554835 is sponsored by LMU Klinikum. The principal investigator is Thomas Klopstock, Prof. Dr. at LMU Klinikum, Munich. The trial plans to enroll 6,000 participants.